Annexin A5-800CW
Showing 1 - 25 of >10,000
Retinal Vein Occlusion Trial in Groningen (Annexin A5)
Recruiting
- Retinal Vein Occlusion
- Annexin A5
-
Groningen, NetherlandsUMCG
Nov 11, 2021
Glioblastoma, High-grade Glioma Trial in Groningen (Cetuximab-IRDye800)
Recruiting
- Glioblastoma
- High-grade Glioma
-
Groningen, NetherlandsUMCG
Jun 26, 2023
Barrett's Esophagus Without Dysplasia, Barrett Oesophagitis With Dysplasia, Esophageal Adenocarcinoma Trial in Groningen
Not yet recruiting
- Barrett's Esophagus Without Dysplasia
- +2 more
- Avastin
- +2 more
-
Groningen, NetherlandsUniversity Medical Center Groningen
Feb 24, 2023
Colonic Tumors, Sentinel Lymph Node, Fluorescence Trial (Sentinel lymph node identification)
Not yet recruiting
- Colonic Neoplasms
- +3 more
- Sentinel lymph node identification
- (no location specified)
Aug 10, 2022
Esophageal Cancer Trial in Groningen (Bevacizumab-IRDye800CW, Molecular Fluorescence Endoscopy platform)
Recruiting
- Esophageal Cancer
- Bevacizumab-IRDye800CW
- Molecular Fluorescence Endoscopy platform
-
Groningen, NetherlandsUniversity Medical Center Groningen
May 19, 2022
Healthy Trial in Groningen (ANXV, Placebo)
Completed
- Healthy
- ANXV
- Placebo
-
Groningen, NetherlandsQPS Netherlands B.V.
May 12, 2022
Sepsis Trial in Nanjing (SY-005, Placebo)
Recruiting
- Sepsis
- SY-005
- Placebo
-
Nanjing, Jiangsu, ChinaZhongda Hospital,Affiliated to Southeast University
Feb 27, 2022
Coronavirus Infection, Sepsis Trial in London (recombinant human annexin A5, Placebo)
Recruiting
- Coronavirus Infection
- Sepsis
- recombinant human annexin A5
- Placebo
-
London, Ontario, CanadaLondon Health Sciences Centre
Apr 23, 2021
Oral Cancer, Lymph Node Metastases Trial in Groningen (MSOT Acuity Echo)
Recruiting
- Oral Cancer
- Lymph Node Metastases
- MSOT Acuity Echo
-
Groningen, NetherlandsUniversity Medical Center Groningen
Apr 30, 2021
Carcinoma, Renal Cell Trial in Nijmegen (drug, radiation, procedure)
Recruiting
- Carcinoma, Renal Cell
-
Nijmegen, NetherlandsRadboudumc
Sep 23, 2021
Crohn Disease, Colitis, Ulcerative Trial in Groningen (Vedolizumab-800CW, Fluorescence endoscopy and spectroscopy)
Recruiting
- Crohn Disease
- Colitis, Ulcerative
- Vedolizumab-800CW
- Fluorescence endoscopy and spectroscopy
-
Groningen, NetherlandsUniversity Medical Center Groningen
Apr 27, 2021
Relapsed Lymphoid Malignancies, Refractory Lymphoid Malignancies Trial in Bentleigh (CN1, 0.5mg/kg and CN401, 400mg, CN1, 1mg/kg
Terminated
- Relapsed Lymphoid Malignancies
- Refractory Lymphoid Malignancies
- CN1, 0.5mg/kg and CN401, 400mg
- +4 more
-
Bentleigh, Victoria, AustraliaMonash Health - Monash Medical Centre
Oct 20, 2022
Neonatal Neurobehavior, Breastfeeding Outcomes Trial in Cleveland (Bolus 10mL 0.25% bupivacaine/ep 1:600,000; infusion 10mL/hour
Withdrawn
- Neonatal Neurobehavior
- Breastfeeding Outcomes
- Bolus 10mL 0.25% bupivacaine/ep 1:600,000; infusion 10mL/hour 0.25% bupivacaine and epi 1:800,000
- +3 more
-
Cleveland, OhioUniversity Hospitals Case Medical Center
Apr 13, 2022
Primary Soft-tissue Sarcoma Trial in Lebanon (ABY-029)
Completed
- Primary Soft-tissue Sarcoma
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Aug 25, 2021
Head Neck Cancer Trial in Lebanon (ABY-029)
Completed
- Head and Neck Cancer
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Aug 17, 2021
Barrett Esophagus Trial in Groningen (Bevacizumab-IRDye800CW, Fluorescence endoscopy)
Recruiting
- Barrett Esophagus
- Bevacizumab-IRDye800CW
- Fluorescence endoscopy
-
Groningen, NetherlandsUniversity Medical Center Groningen
Nov 3, 2020
Healthy Trial in Basel (Placebo, Mescaline 100mg, Mescaline 200mg)
Recruiting
- Healthy
- Placebo
- +5 more
-
Basel, BS, SwitzerlandUniversity Hospital Basel, Clinical Trial Unit
Aug 17, 2021
Rectal Cancer Trial in Groningen (Cetuximab-IRDye800, Fluorescent molecular endoscopy and surgery)
Recruiting
- Rectal Cancer
- Cetuximab-IRDye800
- Fluorescent molecular endoscopy and surgery
-
Groningen, NetherlandsUniversity Medical Center Groningen
Nov 16, 2020
COPD Trial in Manchester (CHF 1535 NEXThaler 800/48, CHF 1535 NEXThaler 200/12, CHF 1535 NEXThaler PLACEBO)
Completed
- COPD
- CHF 1535 NEXThaler 800/48
- +4 more
-
Manchester, United KingdomMedicine Evaluation Unit
Oct 28, 2021
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Groningen (Fluorescence guided detection of tumor positive
Not yet recruiting
- Head and Neck Cancer
- Head and Neck Squamous Cell Carcinoma
- Fluorescence guided detection of tumor positive margins
- Cetuximab-IRDye800
-
Groningen, NetherlandsUniversity Medical Center Groningen
Aug 10, 2022